What's Behind Bio-Rad Laboratories' Q4 Earnings Miss

Bio-Rad Laboratories (NYSE: BIO) delivered a fantastic performance in 2019, with shares skyrocketing 59%. But so far this year, the stock hasn't gotten off to a great start.

The company announced its 2019 fourth-quarter and full-year results after the market closed on Thursday. Here are the highlights from Bio-Rad's Q4 update.

Image Source: Getty Images.

Continue reading

Source Fool.com